May 11, 2005 — The Irish healthcare company Alltracel Pharmaceuticals announced today that it signed an agreement with a Czech nanofiber specialist to create products for treating wounds. Alltracel, which is headquartered in Dublin and has a research and development branch in the Czech Republic, will work with Prague-based Elmarco to further develop nanofiber prototypes for the surgical and healthcare markets.

Elmarco specializes in advanced manufacturing for the semi-conductor components industry as well as equipment for industrial production of nanofibrous non-woven materials. It has partnered with the textile faculty at the Technical University of Liberic to develop a patented process for spinning polymers into nanoscale fibers for a range of industrial, chemical, microelectronic and biomedical applications.